ICU Medical (NASDAQ:ICUI) Cut to Hold at StockNews.com

StockNews.com cut shares of ICU Medical (NASDAQ:ICUI) from a buy rating to a hold rating in a report published on Monday morning.

Several other research firms have also recently weighed in on ICUI. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, December 11th. KeyCorp increased their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Finally, Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $168.67.

ICU Medical Stock Performance

ICUI opened at $141.59 on Monday. The company has a market capitalization of $3.47 billion, a price-to-earnings ratio of -30.98 and a beta of 0.73. ICU Medical has a 1 year low of $93.36 and a 1 year high of $196.26. The business’s 50-day moving average price is $157.96 and its two-hundred day moving average price is $165.25. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Insider Activity

In related news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 6.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On ICU Medical

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in ICU Medical by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock worth $416,176,000 after acquiring an additional 17,805 shares in the last quarter. State Street Corp grew its stake in shares of ICU Medical by 9.3% during the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after acquiring an additional 77,506 shares during the period. JPMorgan Chase & Co. grew its position in shares of ICU Medical by 7.4% in the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock valued at $109,920,000 after purchasing an additional 49,108 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after acquiring an additional 48,106 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock valued at $83,788,000 after buying an additional 82,982 shares during the period. Institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.